Biomea Fusion Statistics
Total Valuation
Biomea Fusion has a market cap or net worth of $153.29 million. The enterprise value is $74.90 million.
Important Dates
The last earnings date was Tuesday, October 29, 2024, after market close.
| Earnings Date | Oct 29, 2024 |
| Ex-Dividend Date | n/a |
Share Statistics
Biomea Fusion has 36.24 million shares outstanding. The number of shares has increased by 10.63% in one year.
| Current Share Class | 36.24M |
| Shares Outstanding | 36.24M |
| Shares Change (YoY) | +10.63% |
| Shares Change (QoQ) | +0.49% |
| Owned by Insiders (%) | 12.70% |
| Owned by Institutions (%) | 53.99% |
| Float | 22.46M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | n/a |
| Forward PS | n/a |
| PB Ratio | 2.02 |
| P/TBV Ratio | 2.02 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 3.39, with a Debt / Equity ratio of 0.13.
| Current Ratio | 3.39 |
| Quick Ratio | 3.19 |
| Debt / Equity | 0.13 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is -104.51% and return on invested capital (ROIC) is -63.64%.
| Return on Equity (ROE) | -104.51% |
| Return on Assets (ROA) | -56.38% |
| Return on Capital (ROIC) | -63.64% |
| Revenue Per Employee | n/a |
| Profits Per Employee | -$1.40M |
| Employee Count | 103 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -70.21% in the last 52 weeks. The beta is -0.55, so Biomea Fusion's price volatility has been lower than the market average.
| Beta (5Y) | -0.55 |
| 52-Week Price Change | -70.21% |
| 50-Day Moving Average | 8.05 |
| 200-Day Moving Average | 8.91 |
| Relative Strength Index (RSI) | 26.66 |
| Average Volume (20 Days) | 1,081,009 |
Short Selling Information
The latest short interest is 9.92 million, so 27.37% of the outstanding shares have been sold short.
| Short Interest | 9.92M |
| Short Previous Month | 9.41M |
| Short % of Shares Out | 27.37% |
| Short % of Float | 44.16% |
| Short Ratio (days to cover) | 12.98 |
Income Statement
| Revenue | n/a |
| Gross Profit | n/a |
| Operating Income | -151.32M |
| Pretax Income | -139.65M |
| Net Income | -144.01M |
| EBITDA | -149.63M |
| EBIT | -151.32M |
| Earnings Per Share (EPS) | -$4.00 |
Full Income StatementBalance Sheet
The company has $87.95 million in cash and $9.57 million in debt, giving a net cash position of $78.39 million or $2.16 per share.
| Cash & Cash Equivalents | 87.95M |
| Total Debt | 9.57M |
| Net Cash | 78.39M |
| Net Cash Per Share | $2.16 |
| Equity (Book Value) | 75.97M |
| Book Value Per Share | 2.10 |
| Working Capital | 66.03M |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was -$112.73 million and capital expenditures -$288,000, giving a free cash flow of -$113.02 million.
| Operating Cash Flow | -112.73M |
| Capital Expenditures | -288,000 |
| Free Cash Flow | -113.02M |
| FCF Per Share | -$3.12 |
Full Cash Flow StatementMargins
| Gross Margin | n/a |
| Operating Margin | n/a |
| Pretax Margin | n/a |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |